JT
ADPT icon

Jupiter Topco’s Adaptive Biotechnologies ADPT Stock Holding History

Jupiter Topco’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
+46,900
New +$719K ﹤0.01% 1801

Other funds holding ADPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jupiter Topco's ADPT Position: Q2 2026 in Review

Jupiter Topco opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 46,900 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #1801 among its holdings.

280 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Jupiter Topco held 46,900 shares of Adaptive Biotechnologies worth $1.01M as of Q2 2026.
  • Adaptive Biotechnologies was a new Jupiter Topco position in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1801 holding.
  • 280 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.